N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118
Online ISSN 1827-1634
Suja PADMANABHAN 1, 2, Monica ZEN 3, Vincent LEE 2, 4, 5, Ngai W. CHEUNG 1, 2
1 Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia; 2 School of Medicine, University of Sydney, Sydney, Australia; 3 Department of Obstetrics and Gynecology, Westmead Hospital, Sydney, Australia; 4 Department of Renal Medicine, Westmead Hospital, Sydney, Australia; 5 Centre for Transplant and Renal Research, Westmead Millennium Institute, Sydney, Australia
The incidence of type 1 and type 2 diabetes amongst women of reproductive age is increasing worldwide. Despite recent advances in treatment options for diabetes outside of pregnancy, women still have a significantly increased risk of adverse obstetric outcomes including perinatal death and congenital malformation, compared to the non-diabetic population. An understanding of the physiological changes during pregnancy, management, early detection and prevention of complications and pre-pregnancy care, specific to women with pre-existing diabetes, is important in improving health outcomes in this growing group of women. This review particularly focuses on areas where there have been recent developments or controversy.